The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of ANDES-1537: A novel antisense oligonucleotide against non-coding mitochondrial DNA in advanced solid tumors.
 
Mallika Sachdev Dhawan
Consulting or Advisory Role - Driver Group
 
Rahul Raj Aggarwal
Research Funding - Gilead Sciences; Novartis; Sanofi; Zenith Epigenetics
 
Emily Boyd
No Relationships to Disclose
 
Kathleen Comerford
No Relationships to Disclose
 
Jenna Zhang
No Relationships to Disclose
 
Bernadita Méndez
Employment - Andes Biotechnologies
Leadership - Andes Biotechnologies
Stock and Other Ownership Interests - Andes Biotechnologies
 
Pablo Valenzuela
Employment - Andes Biotechnologies
Leadership - Andes Biotechnologies
Stock and Other Ownership Interests - Andes Biotechnologies
 
Jennifer Grabowsky
No Relationships to Disclose
 
Scott Thomas
No Relationships to Disclose
 
Pamela N. Munster
Stock and Other Ownership Interests - OncoSec (I)
Honoraria - Amgen (I); Prometheus (I); Threshold Pharmaceuticals
Consulting or Advisory Role - HUYA Bioscience International
Research Funding - Andes Biotechnologies (Inst); Biomarin (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Intellikine (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); OncoMed (Inst); Onconova Therapeutics (Inst); oncosec (Inst); Pfizer (Inst); Piramal Life Science (Inst); Plexxikon (Inst); Sanofi (Inst)